MARKET

OKUR

OKUR

OnKure Therapeutics
NASDAQ
4.550
+0.050
+1.11%
Opening 09:58 06/29 EDT
OPEN
4.540
PREV CLOSE
4.500
HIGH
4.670
LOW
4.500
VOLUME
42.20K
TURNOVER
--
52 WEEK HIGH
5.38
52 WEEK LOW
1.910
MARKET CAP
183.80M
P/E (TTM)
-1.0516
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OKUR last week (0622-0626)?
Weekly Report · 4h ago
Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)
TipRanks · 4d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 6d ago
Weekly Report: what happened at OKUR last week (0615-0619)?
Weekly Report · 06/22 09:10
Weekly Report: what happened at OKUR last week (0608-0612)?
Weekly Report · 06/15 09:10
These healthcare stocks are combining strong gains with reasonable prices
Seeking Alpha · 06/12 10:38
Weekly Report: what happened at OKUR last week (0601-0605)?
Weekly Report · 06/08 09:10
OnKure Shareholders Approve Amended 2024 Equity Incentive Plan
TipRanks · 06/04 22:08
More
About OKUR
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Company is building a pipeline of tumor-agnostic candidates. It is developing OKI-219, a selective PI3KaH1047R inhibitor, as its lead program. It is engaged in targeting oncogenic PI3Ka and has multiple programs designed to enable targeting of this key oncogene. It is focused on delivering highly selective drug candidates that preserve wild-type PI3Ka while targeting the PI3Ka-mutated cancers, initially in advanced breast cancer. Its lead product candidate, OKI-219, is advancing in a phase I clinical trial. It also focuses on a development candidate targeting the most common PI3Ka mutations, such as H1047R, E545K, and E542K. Additionally, it is developing an allosteric inhibitor molecule.

Webull offers Onkure Therapeutics Inc stock information, including NASDAQ: OKUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OKUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OKUR stock methods without spending real money on the virtual paper trading platform.